Eli Lilly Corp. buy Argus
Start price
14.05.24
/
50%
€703.10
Target price
14.05.25
€776.16
Performance (%)
-8.83%
End price
15.05.25
€641.00
Summary
This prediction ended on 15.05.25 with a price of €641.00. With a performance of -8.83%, the BUY prediction by Argus finished with a loss. A total of €5.04 was paid as dividends for this prediction. Argus has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Eli Lilly Corp. | 0.922% | 0.922% | 16.410% |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% |
Comments by Argus for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (NYSE: LLY) had its price target raised by analysts at Argus from $770.00 to $840.00. They now have a "buy" rating on the stock.
Ratings data for LLY provided by MarketBeat
In the thread Trading Eli Lilly Corp.
Die von Argus gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Argus for Eli Lilly Corp.
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€520.50
05.09.23
05.09.23
€578.15
05.09.24
05.09.24
57.33%
06.09.24
06.09.24

